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The ideal adrenaline concentration remains unknown. 
Aim: Compare topical adrenaline solutions in different 
concentrations. Study design: Prospective, double blind, 
randomized trial. Patients and methods: 49 patients divided 
in 3 groups underwent endoscopic sinus surgery, using only 
topical solutions of adrenaline in different concentrations 
(1:2,000, 1:10,000 and 1:50,000). We compared the duration 
of surgery, intra-operative bleeding, plasmatic levels of 
catecholamines, hemodynamic parameters and changes in 
heart rhythm. Results: Surgery time was shorter in the group 
using adrenaline 1:2,000, which also showed less bleeding 
in all evaluations (objective and subjective - p < 0.0001). 
Plasmatic levels of epinephrine rose in all groups, more 
sharply in the 1:2,000 group. There was a trend towards 
elevation of blood pressure in the groups using adrenaline 
1:2,000 and 1:10,000, with a greater occurrence of hypertensive 
peaks. Discussion: We found a very significance bleeding 
difference favoring the 1:2,000. The blood pressure elevation 
in the 1:2,000 and 1:10,000 groups was progressive but very 
slow throughout the procedure, which could be associated 
with the anesthesia technique. Conclusion: We favor the 
use of topical adrenalin 1:2,000 due to a clear superiority in 
hemostasis. Further investigation is needed to corroborate 
our findings.
Keywords: paranasal sinus diseases, epinephrine, hemostasis 
surgical, norepinephrine, nasal polyps.
ORIGINAL ARTICLE
Braz J Otorhinolaryngol.
2009;75(2):280-9.
281
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 75 (2) MARCH/APRIL 2009
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
A limiting factor in nose surgery has been the di-
fficulty in manipulating surgical instruments in the nasal 
fossae and attaining a good view of the operating field. 
The main hurdles against an adequate view for surgeons 
are a narrow and tortuous nasal fossa anatomy, inadequate 
lighting, and abundant bleeding of the mucosa due to the 
rich local vascularization.
Nasal endoscopic surgery, which started in the 
early 70s, substantially minimized the first two hurdles 
mentioned above. Endoscopes can reach further, magnify 
the field of view, and provide angulated optics, which has 
enabled surgeons to reach until then inaccessible recesses.1 
However, the third hurdle - bleeding - has in a way incre-
ased. With surgery being guided by an endoscopic image, 
any minor bleeding that covers the tip of the endoscope 
may cloud the surgeon’s view. Thus, hemostasis of the 
nasal mucosa, which was already important, has become 
paramount for operability.
Except for septoplasty, in which some authors find 
no benefit in using vasoconstrictive solutions,2,3 all other 
surgeries use these agents for controlling blood loss. The 
use of cocaine and its derivatives have been widely used. 
However, its price and use for illicit ends has led many 
countries to ban these substances. Adrenalin has become 
popular because it is inexpensive and available in nearly 
every hospital.
The major difficulty with adrenalin is to establish 
the dose that provides the best safety and efficacy; there 
is no standard concentration defined for this substance 
in the medical literature. Furthermore, when applying 
adrenalin topically, the total amount that is used is hard 
to establish.
Adrenalin concentrations - when mentioned - have 
varied widely in the literature, ranging from 1:200 000 
to 1:1 000 for topical use, and 1:200 000 to 1:50 000 for 
infiltration.1,4,5 The idea that higher concentrations of adre-
nalin are needed for improved operability in nasal endos-
copic surgery has subtly gained strength. This has been 
due mostly to the protocols used in health care centers 
with more experience in endoscopic surgery worldwide, 
which adopt concentrations for topical use of 1:5 000, 1:2 
000 or 1:1 000.6,1
Although there has been a world trend to use more 
concentrated solutions, studies demonstrating improved 
hemostasis and safety (incidence of systemic effects) with 
these concentrations, compared to lower concentrations, 
are lacking. Systemic side effects are proportional to the 
absorption of adrenalin, another topic that has been po-
orly investigated.
The purpose of this study was to compare the topi-
cal use of adrenalin solutions at different concentrations in 
nasal endoscopic surgery, assessing its efficacy in hemos-
tasis, systemic absorption, and onset of adverse effects.
PATIENTS AND METHODS
A prospective controlled double-blind study was 
done on a sample of randomly selected patients. The Re-
search Ethics Committee of the Hospital X approved this 
study (approval number 207/04 - CEP).
Fifty-four consecutive patients aged over 18 years 
undergoing endoscopic nasal surgery for the treatment of 
nasosinusal polyposis at our hospital were selected.
Inclusion and exclusion criteria are shown on Ta-
ble 1. Before surgery, all patients were assessed with an 
electrocardiogram, the prothrombin time (PT), the activa-
ted partial thromboplastin time (PTT), and a surgical risk 
assessment by a clinician or cardiologist. Only patients 
classified preoperatively as ASA class I or II (American 
Society of Anesthesiology) were included.7 Patients with 
signs of cardiac disease, elevated systemic blood pressure, 
or blood dyscrasia were excluded. Eligible patients signed 
a free informed consent form.
All patients were given prednisone (40 mg/day) 
during five days before surgery, followed by gradual re-
moval postoperatively.
Patients were chosen randomly by a draw to one 
of three study groups, according to the concentration of 
adrenalin used during surgery: 1% lidocaine solution with 
adrenalin at 1:2 000, 1:10 000 or 1:50 000 concentrations. 
An anesthesiologist who was not involved in the surgery 
prepared the solution. Surgeons and the surgical team were 
unaware of which solution was used. The anesthesiologist 
that was involved in the surgery was also unaware of the 
concentration, but could request this information if it was 
deemed necessary at any point during surgery.
 
Anesthesia
Preanesthetic sedation was not used in any patient. 
Induction of anesthesia was done in all patients with 
propofol and alfentanil. Maintenance of anesthesia was 
done with propofol and fentanil, repeating the doses as 
needed. Muscle relaxation was attained with rocuronium 
and/or atracurium. Controlled positive pressure ventilation 
(33% oxygen in nitrous oxide) was used in all cases. The 
inhaled anesthetic was isoflurane.
 
Using the adrenalin solution
Adrenalin solutions were used topically. Cotton 
strips were imbibed with the solution; the excess was 
carefully removed until the cotton strip was saturated but 
not dripping even upon compression. Removal of the 
excess solution was done over the recipient containing 
the solution to avoid waste. Each strip absorbed about 1 
ml of the solution. The cotton strips were then inserted 
in the nasal fossae (one each side) for 4 minutes in all of 
the surgeries.
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During the operation, the surgeon could use the 
cotton strips again for hemostasis; the strips were always 
prepared in the same manner. Each surgery used 20 cot-
ton strips. After the first use, each cotton strip was kept in 
contact with the nasal fossa for 2 minutes. In reuse, each 
strip was placed in the nasal fossa that was not being 
operated on at that particular moment, while the surgeon 
operated on the other side, to avoid increasing the surgical 
time. In all cases at the end of surgery, 20 ml of the topical 
solution had been used in the cotton strips, which were 
kept in contact with the nasal mucosa during 40 minutes 
in each case. Thus, the total quantity of adrenalin that 
was given was 400 μg in the 1:50 000 solution, 2 000 μg 
(2 mg) in the 1:10 000 solution, and 10 000 μg (10 mg) in 
the 1:2 000 solution.
The surgeries were carried out by the same surge-
ons (the main researcher). The electrocautery was used 
parsimoniously to minimize damage to the nasal mucosa 
and to avoid prolonged postoperative healing.
 
Assessing the extent of disease
The extent of nasosinusal polyposis was estimated 
by the number of anatomical structures that were operated 
in each surgery (inferior turbinate, middle turbinate, eth-
moid bulla, unciform process, posterior ethmoid, sphenoid, 
and frontal recess, counted for each nasal fossa), based 
on the principle that the number of structures that need 
operating is correlated with the extent of disease. We used 
the term procedure to describe the operation on each 
anatomical structure. Thus, the number of procedures in 
each surgery was recorded.
 
Assessing perioperative bleeding
Three forms of evaluating bleeding were used: vo-
lume of aspirated blood, the surgeon’s grade of bleeding, 
and an assessment of bleeding based on a visual-analog 
scale by the surgeon.
At the beginning of each surgery, gauze was pla-
ced on the rhinopharynx to stop blood from reaching the 
pharynx. The volume of saline used during surgery was 
measured. At the end of surgery, the total amount of aspi-
rated blood was measured. Blood absorbed by the gauze 
or cotton strips with adrenalin was not included, as was 
not any blood that the patient swallowed.
At the end of surgery, the surgeon classified perio-
perative subjectively; this was done grading the amount of 
bleeding from “A” to “D” as shown on Table 2, and using 
a visual-analog scale to score the amount of bleeding from 
“no bleeding” to “extreme bleeding”. The distance from the 
left tip of the scale until the grade given by the surgeon 
was measured to one decimal point, which resulted in a 
0 to 10 score for bleeding.
 
Dosing plasma catecholamines
Plasma catecholamines (adrenalin and noradrenalin) 
were dosed three times in each patient. The first sample 
was taken 10 to 15 minutes after induction of anesthesia, 
before any surgical stimulation or use of vasoconstrictors. 
The second sample was taken after using the tenth cotton 
strip with adrenalin, and the third sample was collected 
after having used the last cotton strip with adrenalin, which 
roughly coincided with the end of surgery.
Tubes containing ethylenediaminetetraacetic acid 
(EDTA-K3) and a 10 ml syringe (both cooled to -4ºC prior 
to collecting the sample) were used. The samples at -4ºC 
were immediately centrifuged at 3 000 rotations per minute 
during 10 minutes. Next, plasma was separated and stored 
at -80ºC until the moment of analysis.
Plasma catecholamines were measured by liquid 
chromatography with electrochemical detection. This 
technique was meticulously described by Causon et al. 
in 1981.8
Normal limits for the analyses above are adrenalin 
≤ 115 pg/ml and noradrenalin = 70 to 750 pg/ml.
 
Recordings of the heart rate, blood pressure and heart 
rhythm
The arterial blood pressure was measured and 
recorded automatically every three minutes between 
the point when the first and third blood sample were 
collected. The heart rate was measured continuously on 
a cardioscope. The heart rate measured jointly with the 
arterial blood pressure every three minutes were used for 
further analysis. At any point if the heart rate was above 
115 beats per minute or less than 55 beats per minute, this 
value was also recorded. The heart rhythm was monitored 
throughout surgery to check for arrhythmias.
Normal and elevated heart rate and arterial systolic 
and diastolic pressures were defined according to the 
Seventh Report of the Joint National Committee on the 
Prevention, Detection, Evaluation, and Treatment of High 
Blood Pressure.9,10
 
Control group
As it was not possible to have a control group of 
patients undergoing nasal endoscopic surgery without va-
soconstrictors, a control group was established containing 
patients undergoing tonsillectomy under general anesthe-
sia with the same anesthesiological protocol without the 
use of topical or infiltrated adrenalin. Three blood samples 
were taken from each patient during surgery to measure 
plasma catecholamines; additionally, perioperative hemo-
dynamic parameters were measured.
The control group was also used for comparing 
the cardiovascular parameters and the levels of plasma 
catecholamines. Comparisons of surgical times and pe-
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rioperative bleeding were made among the three study 
groups that underwent nasal endoscopic surgery, since 
there was no sense in comparing these parameters among 
different surgeries.
 
Data analysis
A multivariate analysis was made to verify whether 
there was any statistically significant difference in the 
results among the groups; additional analyses included 
a comparison of the sex distribution, age, and severity 
of disease. The one-way analysis of variance, or the 
non-parametric Kruskal-Wallis ANOVA was used for the 
comparison among three (or four) groups; some variables 
did not have a normal (Gaussian) distribution.
The multiple comparison Tukey test, or the corres-
ponding non-parametric test based on the Kruskal-Wallis 
statistics, was applied to identify the groups that differed 
among themselves.11 The Dunnet multiple comparisons 
test was applied to identify the experimental groups that 
differed from the control group. The chi-square (c2) test 
or Fisher’s exact test were used for comparing qualitative 
variables among the groups. The repeated measures ANO-
VA was applied to analyze the behavior of measurements 
across time (three or six assessments) for each group 
separately. The Bonferroni multiple comparisons test (ad-
justed for repeated measures) was applied to identify the 
moments that differed. The one factor repeated measures 
ANOVA was applied to verify whether behavior across 
time differed among the groups.
The significance level was 5%.
RESULTS
Five of 54 patients who signed the free informed 
consent form were eventually excluded, 2 because the 
adrenalin solution was applied inadvertently in the nasal 
fossae before the first blood sample had been taken, and 
3 because the blood samples were handled inadequately. 
Thus, 49 patients were left for the analyses; these patients 
were allocated randomly to the three groups. The control 
group consisted of 10 patients.
There was no sex or age difference among groups; 
the age ranged from 18 to 54 years (mean - 34.2 years). 
The histopathological diagnosis of nasosinusal polyposis 
was confirmed for all patients in the study groups.
There was no statistically significant difference 
among the three groups as to the procedures (anatomical 
structures that were operated); this led us to assume that 
there was a homogeneous distribution of the severity of 
disease among groups. The mean was 10.6 procedures 
per surgery.
 
Operative time
The mean operative time was 1602 minutes in the 
adrenalin 1:2 000 group, 171.5 minutes in the adrenalin 
1:10 000 group, and 190.1 minutes in the adrenalin 1:50 
000 group. Although different, these values were not sta-
tistically significant (p value = 0.075). This was because 
the operative time varied widely in each group.
To overcome this difficulty, the analysis of opera-
tive time was made based on each procedure, obtained 
by dividing the operative time of each surgery by the 
number of procedures done in each. The operative time 
by procedure was 16.1 minutes in the adrenalin 1:2 000 
group, 18 minutes in the adrenalin 1:10 000 group, and 19.1 
minutes in the adrenalin 1:50 000 group. These differences 
were statistically significant (p value = 0.02), showing that 
surgery using adrenalin 1:2 000 took less time.
 
Bleeding
Table 3 shows the, standard deviation (SD), median, 
minimum and maximum subjective scores of bleeding per 
group, the volume of aspirated blood, and the correspon-
ding descriptive level in the statistical test (p value).
The mean bleeding was 140.3 ml in the group in 
which adrenalin 1:2 000 was used, which was 2.4 times 
less than bleeding in the adrenalin 1:10 000 group (mean 
- 336.9 ml), and three times less that bleeding in the adre-
nalin 1:50 000 group (mean - 425.8 ml).
In the subjective assessment of bleeding, only two 
patients were graded “D” - “extreme bleeding” - which did 
not allow the procedure to continue as planned or that 
required a change to a non-endoscopic technique. Both 
patients belonged to the adrenalin 1:50 000 group. In one 
of these cases, bleeding interfered with the opening of the 
sphenoid sinus (as planned beforehand); in the other cases, 
the endoscope had to be left aside, and surgery continued 
with the naked eye and a nasal speculum until adequate 
control of bleeding was attained and the endoscope was 
reapplied. Since only two patients scored “D” for bleeding, 
these were considered as a single group (scores “C” and 
“D”) in the statistical analysis.
The topical adrenalin 1:50 000 group had a signifi-
cantly higher C/D scores (62.5%) compared to the adrena-
lin 1:2 000 group (5.9%) and the adrenalin 1:10 000 group 
(18.8%). On the other hand, the adrenalin 1:2 000 and 
1:10 000 groups had a higher rate of scores A (58.8% and 
31.2%) compared with the adrenalin 1:50 000 group (0%); 
these findings are shown on Chart 1. These differences 
were statistically significant (p value = 0.0002).
In the subjective visual-analog scale for bleeding, 
the score in the adrenalin 1:2 000 group (mean - 1.5 ± 
0.8 SD) was lower compared to the adrenalin 1:10 000 
group (mean - 3.3 ± 1.2 SD), which in turn scored lower 
than the adrenalin 1:50 000 group (mean - 5.3 ±1.2 SD). 
These differences were statistically significant (p value = 
0.0001).
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Table 1. Inclusion and exclusion criteria
Inclusion criteria:
1) Age equal to or over 18 years.
2) Patient with nasosinusal polyposis, for which surgery was indicated.
3) Classified preoperatively as class I (patient with no comorbidities) or class II (mild systemic disease), according to the classification sys-
tem of the American Society of Anesthesiology.7
Exclusion criteria:
1) Patients legally incompetent or unable to provide consent.
2) Pregnant patients.
3) Patients with systemic arterial hypertension.
4) Patients with coronary disease.
5) Patients with cardiac arrhythmias or with any anomalies of the cardiac rhythm in a preoperative electrocardiogram.
6) Patients with collagen vascular diseases.
7) Patients with acute or chronic kidney or liver failure.
8) Patients with coagulation disorders or any type of blood dyscrasias.
9) Patients using sympathomimetic drugs, alpha-agonists, beta-agonists, alpha-blockers, beta-blockers, chlorpromazine, haloperidol, teophi-
lin, aminophilin, cocaine, quinine, reserpine, imipramine, levodopa or anticoagulants.
10) Patients that did not interrupt hypoglycemiant drugs at least 48 hours before surgery or non-steroidal anti-inflammatory drugs at least 4 
weeks before surgery.
11) Patients that were given other muscle relaxants, hypnotic drugs, and volatile anesthetics other than those established in the research 
protocol.
Table 2. Scores of perioperative bleeding.
Score A Minimal bleeding.
Score B Controllable bleeding; did not affect the surgery as planned.
Score C Increased bleeding, affecting the surgery but not impeding its planned outcome using endoscopy.
Score D
Extreme bleeding, that did not allow the procedure to be concluded as planned, or that required a change to a non-endosco-
pic surgery.
Table 3. Statistical analysis of perioperative bleeding variables (in milliliters) for each group.
Group N Mean D.P. Median Minimum Maximum p valuea Significant differencesb
Adrenalin
1:2000
17 140,3 56,7 135 40 270 0,0001
1:2000 ≠ 1:10.000
1:2000 ≠ 1:50.000
1:10.000 ≠ 1:50.000
Adrenalin
1:10.000
16 336,9 20,40 315 85 750
Adrenalin
1:50.000
16 425,8 25,58 334 100 1100
SD: Standard deviation p valuea: Kruskal-Wallis ANOVA for the three study groups.
Sig. dif.b: Tukey’s multiple comparisons test at 5%.
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Dosage of plasma catecholamines
Chart 2 shows the variation of plasma adrenalin 
and noradrenalin levels in the three study groups and the 
control group. Plasma adrenalin levels increased gradually 
as surgery progressed (and in all three measurements) in 
all groups except in the control group (p values = 0.0001; 
0.0001 and 0.0013 for the adrenalin 1:2 000, 1:10 000 and 
1:50 000 groups). The one factor repeated measures ANO-
VA revealed that the increase was higher in the adrenalin 
1:2 000 group compared to the other groups (p value = 
0.0001). In this group, the mean plasma concentration of 
adrenalin reached 198.6pg/ml (a 192% increase relative 
to baseline values, and 1.7 times higher than the normal 
upper limit); the highest recorded peak was 346pg/ml 
(over three times the maximum normal limit, and a 409% 
increase compared to baseline levels). The highest mean 
measure (3rd dosage) in the adrenalin 1:10 000 group 
was 120.6pg/ml; the highest recorded peak was 265pg/
ml. The highest peak in the adrenalin 1:50 000 group was 
111.4pg/ml (a 64% increase compared to baseline levels, 
but still within normal limits); the highest recorded peak 
was 217pg/ml.
Noradrenalin concentrations did not vary significan-
tly in any of the three measurements in all groups. Thus, 
the adrenalin/noradrenalin ratio increased in all groups as 
surgery progressed, except in the control group.
 
Cardiac and cardiovascular hemodynamic parameters
No arrhythmias were detected in any patient during 
perioperative cardiac monitoring.
A comparison of the mean and median heart rates 
(HR), systolic arterial pressure (SAP) and diastolic arte-
rial pressure (DAP) in each group at any given moment 
showed that these measures were within normal limits in 
all groups.
The occurrences of SAP and DAP above normal 
limits (hypertension peaks) revealed a higher number 
of such occurrences in the more concentrated adrenalin 
groups (1:2 000 and 1:10 000), as shown on Table 4. There 
were 53 SAP hypertensive peaks (values ≥ 140 mmHg) 
in the adrenalin 1:2 000 group, and 62 DAP hypertensive 
peaks (values ≥ 90 mmHg); there were similar findings in 
the adrenalin 1:10 000 group (59 SAP peaks and 48 DAP 
peaks). The occurrences of blood pressure peaks in the 
adrenalin 1:50 000 group were only 5 SAP peaks and 20 
DAP peaks. In the control group, in which adrenalin was 
not given, there were 8 SAP measures above normal and 
only 1 DAP measure above normal. The difference in the 
occurrence of hypertensive peaks in the adrenalin 1:2 
000 and 1:10 000 groups compared to the other groups 
was statistically significant (p = 0.0001). There were no 
HR measures or tachycardia significantly above normal 
in any group.
We then attempted to verify it these hypertensive 
peaks were sudden or acute variations of the arterial 
pressure immediately after applying cotton strips with the 
adrenalin solution. We correlated the placement of cotton 
strips with arterial blood pressure measurements taken 
within 10 minutes of applying topically each cotton strip 
with adrenalin. No correlation was established between 
hypertensive peaks and such 10-minute periods.
For the next analysis, occurrences of arterial pres-
sure above normal were divided into two groups: peaks 
in the first half of surgery, and peaks in the second half 
of surgery. Hypertensive peaks were at least twice as fre-
quent in the second half of surgery compared to the first 
half of surgery in the more concentrated adrenalin groups 
(1:2 000 and 1:10 000), as shown on Table 5. This finding 
suggests that pressure levels tend to become more altered 
as surgery progresses.
The behavior of SAP and DAP as surgery progressed 
showed that these values increased gradually in the adre-
nalin 1:2 000 and 1:10 000 groups, which was statistically 
significant (p values = 0.028 and 0.0001 - Chart 3). Even 
with such changes, the mean SAP and DAP measurements 
at the end of surgery remained within normal limits in all 
groups, as mentioned above. This was not the case with 
the HR.
Chart 1. Distribution of intraoperative bleeding concepts (in percen-
tage) per group.
Chart 2. Variations of adrenalin and noradrenalin dose averages throu-
ghout the operation for each group. DP=Standard deviation.
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Table 4. Distribution of the measured hemodynamic parameters as normal and abnormal values for each group.
Parameter Values
Adrenalin 
1:2000
Adrenalin 
1:10.000
Adrenalin 
1:50.000
Group
Control
p valuea
Significant 
differencesb
HR
< 100 bpm 912 (99,2%) 915 (99,9%) 1013 (99,6%) 236 (99,6%)
0,45 None 7 (0,8%) 1 (0,1%) 4 (0,4%) 1 (0,4%)
 0 0 0 0
SAP
< 140 mmHg 866 (94,2%) 857 (93,6%) 1012 (99,5%) 229 (96,6%)
< 0,0001
140~159 
mmHg at 1:2 
000 and 1:10 
000 ≠ 1:50 000 
and Control
160~179 
mmHg at 1:2 
000 and 1:10 
000 ≠ 1:50 000 
 40 (4,3%) 48 (5,2%) 5 (0,5%) 8 (3,4%)
 11 (1,3%) 10 (1,1%) 0 0
 2 (0,2%) 1 (0,1%) 0 0
DAP
< 90 mmHg 857 (93,3%) 868 (94,8%) 997 (98%) 235 (99,2%)
< 0,0001
90~99 mmHg 
at 1:2 000 and 
1:10 000 ≠ 
1:50 000 and 
Control
90 ~ 99 mmHg 52 (5,7%) 45 (4,9%) 18 (1,8%) 1 (0,4%)
100 ~ 109 
mmHg
8 (0,9%) 3 (0,3%) 2 (0,2%) 1 (0,4%)
> or equal to 
110 mmHg
2 (0,1%) 0 0 0
HR = Heart rate SAP = Systolic arterial pressure DAP = Diastolic arterial pressure
MAP = Mean Arterial Pressure p valuea: repeated measures ANOVA
Sig. dif.b: Bonferroni multiple comparisons
Table 5. Distribution of the measured hemodynamic parameters above normal values in each group in relation to operative time.
Parameter Occurrences
Adrenalin con-
centration
First half of opera-
tive time
Second half of 
operative time
p valuea Significant differencesb
HR  
(≥ 100 bpm)
4 1:2000 5 2
0,71 None
7 1:10.000 1 -
1 1:50.000 1 3
1 Controle 1 -
SAP 
(≥ 140 mmHg)
5 1:2000 12 41
0,042
Groups B and C had 
more occurrences in 
the second half compa-
red to group A and the 
Control.
53 1:10.000 18 41
59 1:50.000 2 3
8 Control 3 5
DAP 
(≥ 90 mmHg)
20 Group B (1:2000) 21 41
< 0,05
Groups B and C had 
more occurrences in 
the second half compa-
red to group A and the 
Control.
62
Group C 
(1:10.000)
14 34
48
Group A 
(1:50.000)
12 8
2 Control 2 -
HR = Heart rate SAP = Systolic arterial pressure DAP = Diastolic arterial pressure
MAP = Mean Arterial Pressure p valuea: repeated measures ANOVA
Sig. dif.b: Bonferroni multiple comparisons
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DISCUSSION
Few authors have investigated the effects of vaso-
constrictors on the nasal mucosa. Comparing the results 
of published papers is difficult, since each deals with di-
fferent surgical procedures (septoplasty,2,3,6 turbinectomy,5 
endoscopic surgery of the lateral wall of the nose4,12), a 
variety of administration methods (submucosa, topical 
or both4,6,12,13,14), and vasoconstritors (cocaine, adrenalin, 
phenylephrin,15 oxymetazoline12). Often these studies 
tend to associate more than one vasoconstritor, usually 
adrenaline and cocaine.14,16 In our view, not enough 
information is available about the behavior of each 
vasoconstritor singly on the nasal mucosa; thus, such 
associations are not beneficial for research purposes, 
since they complicate data analysis.
This is the first paper that we know of comparing 
adrenalin solutions (not associated with other vasocons-
tritors) used only topically on the nasal mucosa.
We found the difference in bleeding in the three 
groups extremely significant. In the absence of demons-
trated toxicity, a 2.4 higher effectiveness of the adrenalin 
1:2 000 solution compared with the 1:10 000 solution 
would without any doubt justify its use. But what could 
be said about the toxicity of this drug at various concen-
trations for topical use?
First of all, we may begin with the principle that the 
most important adverse effects depend on the systemic 
absorption of adrenalin following topical use.
It is not enough to show increased plasma levels 
of adrenalin to study systemic absorption. Adrenalin (or 
epinephrine) is not a synthetic substance; it is produced 
by the adrenal gland, which may increase its production 
in response to stressful conditions, including the stress 
of surgery. Thus, there is the need to differentiate an 
increased endogenous production from a possible exo-
genous absorption.
We used two methods to achieve this end. The 
first one is based on the principle that increased endo-
genous production of adrenalin is always accompanied 
by an increased sympathetic tonus and elevated plas-
ma levels of noradrenalin.17 Our findings showed that 
elevated plasma concentrations of adrenalin were not 
followed by increased noradrenalin levels; this suggests 
that increased plasma adrenalin levels were due to exo-
genous absorption of this substance. The second method 
made use of the control group, which was subjected to 
surgical stress, a similar anesthesiological procedure, 
and no vasoconstritor. Plasma adrenalin levels did not 
vary in the control group; this, then, is further evidence 
that there was increased exogenous absorption in the 
adrenalin groups.
We found a gradual increase in the plasma levels 
of adrenalin in all three groups in which it was used; 
these levels were higher in the adrenalin 1:2 000 group. 
In these three groups, however, such increased levels 
were lower than those found when adrenalin is infil-
trated in the nasal submucosa.6,18,19 When this approach 
was used, plasma adrenalin levels were up to 40 times 
higher compared to baseline levels (over 3 000 pg/ml); 
in out study, peak levels were 2 to 3 times higher than 
baseline values (the highest plasma adrenalin level was 
346 pg/ml). This is evidence of a probably difference in 
adrenalin absorption when applied by these two routes. 
In the slower topical absorption, rapid adrenalin meta-
bolism comes into play (its half life is only two minutes), 
and peak concentrations are avoided.
It is true that our measurements were made throu-
ghout the surgery; eventual sudden variations immedia-
tely after each cotton strip was applied may not have 
been measured. However, behavior of hemodynamic 
parameters did not vary suddenly after each cotton strip 
was used, but increased slowly and progressively, sug-
gesting that higher peaks than those we recorded did not 
occur. Furthermore, van Hasselt et al., in a comparison 
of topical and submucosal adrenalin use (associated with 
10% cocaine), had already reached similar conclusions 
about differences in absorption and peak levels between 
both administration routes.6
Since cotton strips with adrenalin were maintained 
in place for about the same time (40 minutes) in all pa-
tients, if we divide the mean plasma adrenalin increase in 
each group by that time, we end up with an elevation rate 
per minute of topical solution use. This rate of increase 
was 3.13pg/ml per minute of use of cotton strips in the 
adrenalin 1:2 000 group, 1.20 pg/ml per minute in the 
adrenalin 1:10 000 group, and 0.95pg/ml per minute in 
the adrenalin 1:50 000 group.
Maximum values in each group (346pg/ml in the 
adrenalin 1:2 000 group, 265 pg/ml in the adrenalin 1:10 
000 group, and 217pg/ml in the adrenalin 1:50 000 group) 
are close to those attained occasionally by the body under 
specific conditions. For instance, intense physical exercise 
Chart 3. Variations in systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) throughout the operation for each group. DP=Standard 
Deviation.
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may raise plasma adrenalin levels to about 350pg/ml wi-
thout any threat to individuals.20 It is, in fact, a beneficial 
adaptation of the body to that condition. Thus, it could 
be said that the peak levels in our sample are not truly 
harmful. Differences could arise depending on the time 
that such levels remained above normal; in surgeries, this 
time was not short.
No patient in our sample manifested cardiac ar-
rhythmias. Arrhythmias associated with adrenalin were 
common when halothane used to be used as an anesthe-
tic, since this drug increases the sensitivity of adrenalin 
myocardial adrenergic receptors. With further develo-
pments in anesthesia, new drugs now provide more 
hemodynamic stability and interact less with adrenalin, 
making adrenalin-related arrhythmias rare.
Similar to plasma adrenalin concentrations, blood 
pressure levels in the more concentrated adrenalin groups 
(1:2 000 and 1:10 000) increased slowly and gradually as 
surgery progressed, which suggests a possible correlation 
between both findings. This did not occur in the control 
group and the adrenalin 1:50 000 group (in the latter 
blood pressures rose slightly, but there was no statistical 
significance).
If we divide the mean increase in SAP and DAP 
levels by the total duration of exposure to the topical 
adrenalin solution, the result is a 0.50 mmHg (SAP) and 
a 0.37 (DAP) mmHg increase rate for each minute of 
topical adrenalin use at 1:2 000. At a concentration of 
1:10 000, the rate is 0.34 mmHg (SAP) and 0.25 mmHg 
per minute of cotton strip use.
Although mean SAP and DAP values were within 
normal limits in all groups even close to the end of 
surgery, hypertensive peaks were more frequent in the 
groups that were given more concentrated adrenalin 
solutions.
Our anesthesia protocol consisted of inhaled and 
venous anesthesia combined. Some papers have sugges-
ted that venous anesthesia is superior for maintaining 
hemodynamic stability, which might have avoided the 
hypertensive peaks we encountered.21,22 Anderhuber et 
al. studied 51 patients that were given a topical adrenalin 
1:1 000 solution associated with submucosal adrenalin 
1:200 000 (in patients under fully venous general anes-
thesia), and found no increases in blood pressure during 
surgery.4 Additional controlled studies, preferably with 
larger series and more homogeneous groups, are needed 
for more definitive conclusions.
CONCLUSION
This study clearly demonstrates the haemostatic 
benefit of adrenalin at 1:2 000. In terms of adverse effects, 
there was a tendency for the systemic arterial pressure to 
increase as more concentrated solutions were used, al-
though mean supraphysiological levels were not reached. 
Concerning this point, the topic remains controversial; 
further studies are thus needed.
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